Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Frederick George Barker II, M.D.

Co-Author

This page shows the publications co-authored by Frederick Barker and William Curry.
Connection Strength

3.750
  1. Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004. Neurosurgery. 2010 Mar; 66(3):427-37; discussion 437-8.
    View in: PubMed
    Score: 0.418
  2. Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol. 2009 May; 93(1):25-39.
    View in: PubMed
    Score: 0.395
  3. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery. 2005 Jul; 57(1):97-108; discussion 97-108.
    View in: PubMed
    Score: 0.302
  4. Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg. 2005 Jun; 102(6):977-86.
    View in: PubMed
    Score: 0.301
  5. Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping. J Neurosurg. 2019 Mar 29; 132(4):1017-1023.
    View in: PubMed
    Score: 0.196
  6. Isocitrate Dehydrogenase Mutations in Low-Grade Gliomas Correlate With Prolonged Overall Survival in Older Patients. Neurosurgery. 2019 02 01; 84(2):519-528.
    View in: PubMed
    Score: 0.194
  7. Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. J Natl Cancer Inst. 2016 Feb; 108(2).
    View in: PubMed
    Score: 0.155
  8. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database. J Clin Neurosci. 2014 Sep; 21(9):1490-6.
    View in: PubMed
    Score: 0.140
  9. Outcomes and patterns of care in adult skull base chondrosarcomas from the SEER database. J Clin Neurosci. 2014 Sep; 21(9):1497-502.
    View in: PubMed
    Score: 0.139
  10. Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q. J Neurooncol. 2009 May; 93(1):115-20.
    View in: PubMed
    Score: 0.099
  11. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery. 2009 Jan; 64(1):56-60; discussion 60.
    View in: PubMed
    Score: 0.096
  12. Limitations of diffusion-weighted imaging in the diagnosis of postoperative infections. Neurosurgery. 2008 Mar; 62(3):577-83; discussion 577-83.
    View in: PubMed
    Score: 0.091
  13. Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas. Neurosurgery. 2007 Oct; 61(4):754-60; discussion 760-1.
    View in: PubMed
    Score: 0.088
  14. Increased prevalence of obesity and obesity-related postoperative complications in male meningioma patients. Clin Neurosurg. 2007; 54:236-40.
    View in: PubMed
    Score: 0.084
  15. High Incidence of Obesity and Obesity-related Postoperative Complications in Male Patients with Meningiomas 900. Neurosurgery. 2006 Aug 01; 59(2):487-488.
    View in: PubMed
    Score: 0.082
  16. Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro Oncol. 2005 Jan; 7(1):49-63.
    View in: PubMed
    Score: 0.073
  17. Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas. Nat Commun. 2022 03 14; 13(1):1325.
    View in: PubMed
    Score: 0.060
  18. A rapid genotyping panel for detection of primary central nervous system lymphoma. Blood. 2021 08 05; 138(5):382-386.
    View in: PubMed
    Score: 0.058
  19. Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations. Neurol Med Chir (Tokyo). 2021 Jun 15; 61(6):385-391.
    View in: PubMed
    Score: 0.057
  20. Adjuvant Radiation Therapy Versus Surveillance After Surgical Resection of Atypical Meningiomas. Int J Radiat Oncol Biol Phys. 2021 01 01; 109(1):252-266.
    View in: PubMed
    Score: 0.054
  21. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas. Neurosurgery. 2019 11 01; 85(5):E910-E916.
    View in: PubMed
    Score: 0.051
  22. Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis. World Neurosurg. 2020 Jan; 133:e804-e812.
    View in: PubMed
    Score: 0.051
  23. A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas. Neurosurgery. 2019 08 01; 85(2):204-210.
    View in: PubMed
    Score: 0.050
  24. Genotype-targeted local therapy of glioma. Proc Natl Acad Sci U S A. 2018 09 04; 115(36):E8388-E8394.
    View in: PubMed
    Score: 0.047
  25. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. J Neurosurg. 2018 04; 128(4):1123-1132.
    View in: PubMed
    Score: 0.043
  26. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol. 2017 04 01; 19(4):535-545.
    View in: PubMed
    Score: 0.043
  27. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro Oncol. 2016 06; 18(6):863-72.
    View in: PubMed
    Score: 0.039
  28. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov. 2015 Nov; 5(11):1164-1177.
    View in: PubMed
    Score: 0.038
  29. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. J Neurosurg. 2016 Jan; 124(1):106-14.
    View in: PubMed
    Score: 0.038
  30. Rapid Intraoperative Molecular Characterization of Glioma. JAMA Oncol. 2015 Aug; 1(5):662-7.
    View in: PubMed
    Score: 0.038
  31. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun. 2014 Dec 24; 2:167.
    View in: PubMed
    Score: 0.036
  32. Delayed complications after anterior craniofacial resection of malignant skull base tumors. J Neurol Surg B Skull Base. 2014 Apr; 75(2):110-6.
    View in: PubMed
    Score: 0.034
  33. Esthesioneuroblastoma: an update on the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. J Neurol Surg B Skull Base. 2014 Feb; 75(1):58-64.
    View in: PubMed
    Score: 0.033
  34. Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium. Neurosurg Focus. 2013 Feb; 34(2):E9.
    View in: PubMed
    Score: 0.032
  35. Proton radiation therapy for primary sphenoid sinus malignancies: treatment outcome and prognostic factors. Head Neck. 2009 Oct; 31(10):1297-308.
    View in: PubMed
    Score: 0.025
  36. The use of nasopharyngeal airways for airway diversion in anterior craniofacial resection. Am J Rhinol. 2008 Sep-Oct; 22(5):529-32.
    View in: PubMed
    Score: 0.024
  37. Esthesioneuroblastoma: the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. Skull Base. 2008 Sep; 18(5):327-37.
    View in: PubMed
    Score: 0.024
  38. Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neurooncol. 2007 Nov; 85(2):171-80.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.